| COVID-19 |
1 |
1 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.97 |
| Pregnancy |
0 |
0.16 |
| Healthcare and Medical Technology |
0 |
0.99 |
| Migraine |
0 |
0.12 |
| HIV Infection |
0 |
0.1 |
| Influenza |
0 |
0.1 |
| Child |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Fatigue |
0 |
0.09 |
| Biologic Therapy |
0 |
0.06 |
| Chronic Fatigue Syndrome |
0 |
0.06 |
| Disability |
0 |
0.06 |
| Immunization |
0 |
0.06 |
| Mechanical Ventilation |
0 |
0.06 |
| Pandemic |
0 |
0.06 |
| Quality of Life |
0 |
0.06 |
| Vaccines |
0 |
0.06 |
| Ventilator |
0 |
0.06 |
| Health Insurance |
0 |
0.04 |
| Revenue and Practice Management |
0 |
0.04 |
| Accomodation |
0 |
0.03 |
| AIDS |
0 |
0.03 |
| Antiviral Agents |
0 |
0.03 |
| Arrhythmia |
0 |
0.03 |
| Brain |
0 |
0.03 |
| Insurance |
0 |
0.03 |
| Medical Innovations |
0 |
0.03 |
| Monoclonal Antibody |
0 |
0.03 |
| Primary Care |
0 |
0.03 |
| Steroids |
0 |
0.03 |
| Stress |
0 |
0.03 |
| Tachycardia |
0 |
0.03 |